Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
NFL
U.S.
2024 Election
Local
World
Science
Technology
AI
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Ozempic can even cut risk of Alzheimer’s disease, study says
Study shows diabetes drug Ozempic also has positive effect in chronic kidney disease
The diabetes drug semaglutide, also known as Ozempic, has a positive effect on patients with chronic kidney disease and obesity. The amount of protein in their urine decreased, as did the degree of inflammation of their kidneys and their blood pressure.
Ozempic Outperformed 7 Diabetes Medications in Reducing the Risk for Alzheimer’s Disease
Semaglutide outperformed 7 diabetes medications in reducing risk of Alzheimer's disease, according to a study of over 1 million patients with type 2 diabetes.
Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
The active ingredient in Ozempic was associated with a 40% to 70% lower risk of a first-time Alzheimer’s diagnosis in diabetes patients.
AZ Central
2d
Diabetes patients worry about insulin shortages as Ozempic use skyrockets
Janel Wright had just days left in her insulin supply in early January when a pharmacist told her there was none of the drug ...
1d
on MSN
As insulin shortages persist, what diabetes patients can do
Advocates for diabetes patients who need insulin to survive worry the nation's supply is unreliable. Meanwhile, use of ...
8h
on MSN
Can Ozempic boost your brain function? Exploring the weight loss drug's many perks
Ozempic and other GLP-1 drugs show promise not only in managing obesity and diabetes but also in reducing Alzheimer's risk. A ...
1d
Ozempic May Be Linked to Lower Risk of Alzheimer’s in People with Type 2 Diabetes
Published in Alzheimer’s & Dementia on Thursday, Oct. 24, the study found that semaglutide — the active ingredient in popular ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback